相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis
Nathaniel J. Rhodes et al.
CRITICAL CARE MEDICINE (2018)
OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam
Shijie Wen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically III Patients
Abdulaziz S. Alobaid et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Mohd H. Abdul-Aziz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patients
Johannes Zander et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Tissue pharmacokinetics of telavancin in healthy volunteers: a microdialysis study
Peter Matzneller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Population Pharmacokinetics of Piperacillin in the Early Phase of Septic Shock: Does Standard Dosing Result in Therapeutic Plasma Concentrations?
Kristina Obrink-Hansen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care
Peter Le Roux et al.
INTENSIVE CARE MEDICINE (2014)
Continuous versus intermittent infusion of cefepime in neurosurgical patients with post-operative intracranial infections
Huawei Huang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course
Mieke Carlier et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis
Jocelyn Teo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
E. Sander Connolly et al.
STROKE (2012)
Preclinical Prediction of Human Brain Target Site Concentrations: Considerations in Extrapolating to the Clinical Setting
Joost Westerhout et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Systematic Evaluation of the Descriptive and Predictive Performance of Paediatric Morphine Population Models
Elke H. J. Krekels et al.
PHARMACEUTICAL RESEARCH (2011)
Pharmacokinetic evaluation of piperacillin-tazobactam
Yoshiro Hayashi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Lewis B. Morgenstern et al.
STROKE (2010)
Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock
Fabio Silvio Taccone et al.
CRITICAL CARE (2010)
Piperacillin penetration into tissue of critically ill patients with sepsis-Bolus versus continuous administration?
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association
Joshua B. Bederson et al.
STROKE (2009)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
An integrated model for the analysis of pharmacokinetic data from microdialysis experiments
K Tunblad et al.
PHARMACEUTICAL RESEARCH (2004)
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation
TP Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis
V Rodriguez-Cerrato et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
分享论文
